Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Noubar Afeyan currently holds 3,924 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Noubar Afeyan has been a net seller of MRNA stock. They have purchased $88.9M and sold $1.7B worth of shares.
Noubar Afeyan's most recent insider trade was on May 21, 2026, when they sold 9,263 shares at $0.00 per share.
Noubar Afeyan serves as Executive at Moderna, Inc. (MRNA). They have executed 407 insider transactions totaling $1.8B over their tenure at the company.
Noubar Afeyan holds the position of Executive at Moderna, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Noubar Afeyan has shown a selling trading pattern, with $88.9M in total purchases and $1.7B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Noubar Afeyan was on Jun 11, 2024, when they sold $4.7M worth of MRNA shares. This transaction involved 31,531 shares at $148.29 per share.
Noubar Afeyan currently owns 3,924 shares of Moderna, Inc. (MRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Noubar Afeyan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Noubar Afeyan has 407 Form 4 filings on record as an insider at Moderna, Inc..
Set alerts for Noubar Afeyan and 40,000+ other insiders.